Variant report
Variant | nsv557714 |
---|---|
Chromosome Location | chr12:21022867-21036533 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6487168 | chr12:21022867-21022868 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs570279885 | chr12:21022930-21022931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184082010 | chr12:21022981-21022982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577704690 | chr12:21023033-21023034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs75621850 | chr12:21023113-21023114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs556888640 | chr12:21023116-21023117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575939219 | chr12:21023132-21023133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541685591 | chr12:21023165-21023166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561754469 | chr12:21023193-21023194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368726323 | chr12:21023208-21023209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs540852146 | chr12:21023218-21023219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs372817315 | chr12:21023235-21023236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188005778 | chr12:21023260-21023261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116464584 | chr12:21023320-21023321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546346670 | chr12:21023334-21023335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs558054721 | chr12:21023450-21023451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11045572 | chr12:21023453-21023454 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs11045573 | chr12:21023492-21023493 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs192285135 | chr12:21023508-21023509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs11519059 | chr12:21023524-21023525 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs545289739 | chr12:21023531-21023532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529601934 | chr12:21023542-21023543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565146616 | chr12:21023543-21023544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7137416 | chr12:21023559-21023560 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs535265168 | chr12:21023574-21023575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113435731 | chr12:21023575-21023576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7137433 | chr12:21023605-21023606 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs537106245 | chr12:21023609-21023610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567321808 | chr12:21023612-21023613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556950076 | chr12:21023621-21023622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552381130 | chr12:21023631-21023632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573669575 | chr12:21023637-21023638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs115465211 | chr12:21023649-21023650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555668773 | chr12:21023727-21023728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs537672413 | chr12:21023782-21023783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs138394128 | chr12:21023784-21023785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7137375 | chr12:21023787-21023788 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs190220061 | chr12:21023788-21023789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371425055 | chr12:21023827-21023828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs143929692 | chr12:21023831-21023832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs376856801 | chr12:21023859-21023860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528933202 | chr12:21023886-21023887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548694948 | chr12:21023900-21023901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs7137499 | chr12:21023915-21023916 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs528729303 | chr12:21023929-21023930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs181588872 | chr12:21023933-21023934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571471587 | chr12:21023934-21023935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537169617 | chr12:21023984-21023985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557060262 | chr12:21024000-21024001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs376523286 | chr12:21024006-21024007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 16397240 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21364760 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 22102821 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 18438408 | CNVD |
Melanoma | 17363583 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Schizophrenia | 23813976 | CNVD |
Schizophrenia | 21346763 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:21020600-21027400 | Weak transcription | A549 | lung |
2 | chr12:21021200-21024600 | Weak transcription | Liver | Liver |
3 | chr12:21024600-21026200 | Strong transcription | Liver | Liver |
4 | chr12:21026200-21027800 | Weak transcription | Liver | Liver |
5 | chr12:21027400-21028400 | Strong transcription | A549 | lung |
6 | chr12:21027800-21029600 | Strong transcription | Liver | Liver |
7 | chr12:21028400-21035800 | Weak transcription | A549 | lung |
8 | chr12:21029600-21032400 | Weak transcription | Liver | Liver |
9 | chr12:21032400-21035400 | Strong transcription | Liver | Liver |
10 | chr12:21034000-21034200 | Enhancers | Rectal Smooth Muscle | rectum |
11 | chr12:21034400-21035000 | Enhancers | Stomach Mucosa | stomach |
12 | chr12:21034400-21035600 | Weak transcription | Rectal Smooth Muscle | rectum |
13 | chr12:21035000-21035400 | Weak transcription | Stomach Mucosa | stomach |
14 | chr12:21035400-21036000 | Enhancers | Stomach Mucosa | stomach |
15 | chr12:21035400-21039000 | Weak transcription | Liver | Liver |
16 | chr12:21035600-21036200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr12:21035600-21036600 | Enhancers | Rectal Smooth Muscle | rectum |
18 | chr12:21035600-21037800 | Enhancers | Colon Smooth Muscle | Colon |
19 | chr12:21035800-21036600 | Enhancers | Duodenum Smooth Muscle | Duodenum |
20 | chr12:21035800-21037000 | Enhancers | Adipose Nuclei | Adipose |
21 | chr12:21035800-21037600 | Enhancers | HUVEC | blood vessel |
22 | chr12:21035800-21038200 | Enhancers | A549 | lung |